MEP41008A - Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis - Google Patents
Use of bradykinin-b2 receptor antagonists for treating osteoarthrosisInfo
- Publication number
- MEP41008A MEP41008A MEP-410/08A MEP41008A MEP41008A ME P41008 A MEP41008 A ME P41008A ME P41008 A MEP41008 A ME P41008A ME P41008 A MEP41008 A ME P41008A
- Authority
- ME
- Montenegro
- Prior art keywords
- bradykinin
- receptor antagonists
- diseases
- treating osteoarthrosis
- osteoarthrosis
- Prior art date
Links
- 201000008482 osteoarthritis Diseases 0.000 title abstract 3
- 229940123765 Bradykinin B2 receptor antagonist Drugs 0.000 title 1
- 239000003359 bradykinin B2 receptor antagonist Substances 0.000 title 1
- 230000006378 damage Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 206010067632 Cartilage atrophy Diseases 0.000 abstract 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 210000003127 knee Anatomy 0.000 abstract 1
- 210000003041 ligament Anatomy 0.000 abstract 1
- 230000005499 meniscus Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000005801 spondylosis Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/043—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Peptidi sa bradikinin-antagonističkim djelovanjem dolaze u obzir za proizvodnju ljekova za profilaksu i terapiju oboljenja, na čiji tok utiče pojačana aktivnost metaloproteinaze matrice.Tu spadaju oboljenja kao što su degenerativna oboljenja zglobova, primjera radi osteoartoza, spondiloza i atrofija hrskavice posle traume zgloba ili dugotrajne imobilizacije zgloba posle oštećenja meniskusa ili čašice koljena ili povrede ligamenata.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10304994A DE10304994A1 (de) | 2003-02-07 | 2003-02-07 | Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose |
| PCT/EP2004/000550 WO2004069266A2 (de) | 2003-02-07 | 2004-01-23 | Die verwendung von antagonisten des bradykinin-b2 rezeptors zur behandlung von osteoarthrose |
| YUP-2005/0565A RS51029B (sr) | 2003-02-07 | 2004-01-23 | Upotreba antagonista bradikinin-b2 receptora za lečenje osteoartroze |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP41008A true MEP41008A (en) | 2011-02-10 |
Family
ID=32797325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-410/08A MEP41008A (en) | 2003-02-07 | 2004-01-23 | Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1594520B1 (bs) |
| JP (1) | JP2006516980A (bs) |
| KR (1) | KR20050105447A (bs) |
| CN (1) | CN1317029C (bs) |
| AR (1) | AR043036A1 (bs) |
| AT (1) | ATE335500T1 (bs) |
| AU (1) | AU2004210396A1 (bs) |
| BR (1) | BRPI0407333A (bs) |
| CA (1) | CA2514152C (bs) |
| CO (1) | CO5690613A2 (bs) |
| CY (1) | CY1105708T1 (bs) |
| DE (2) | DE10304994A1 (bs) |
| DK (1) | DK1594520T3 (bs) |
| ES (1) | ES2268622T3 (bs) |
| HR (1) | HRP20050701B1 (bs) |
| IL (1) | IL169899A0 (bs) |
| MA (1) | MA27618A1 (bs) |
| ME (1) | MEP41008A (bs) |
| MX (1) | MXPA05007310A (bs) |
| MY (1) | MY135827A (bs) |
| NO (1) | NO333903B1 (bs) |
| NZ (1) | NZ541680A (bs) |
| PE (1) | PE20040939A1 (bs) |
| PL (1) | PL206412B1 (bs) |
| PT (1) | PT1594520E (bs) |
| RS (1) | RS51029B (bs) |
| RU (1) | RU2329057C2 (bs) |
| TW (1) | TW200505472A (bs) |
| WO (1) | WO2004069266A2 (bs) |
| ZA (1) | ZA200505177B (bs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0710522D0 (en) * | 2007-06-01 | 2007-07-11 | Royal Veterinary College The | Drug delivery system comprising matrix metalloproteinase inhibitors |
| IT1391236B1 (it) | 2008-07-11 | 2011-12-01 | St Luso Farm D'italia Spa | Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
| MX9100717A (es) * | 1990-08-24 | 1992-04-01 | Syntex Inc | Antagonistas de la bradiquinina |
| FR2751650B1 (fr) * | 1996-07-24 | 1998-10-09 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
| FR2751878B1 (fr) * | 1996-07-30 | 1998-09-04 | Oreal | Utilisation dans une composition d'un extrait d'au moins une labiee |
| US6346519B1 (en) * | 1998-09-09 | 2002-02-12 | Advanced Medical Instruments | Method and composition for treating arthritis |
| CA2364178C (en) * | 2000-12-05 | 2006-01-10 | Yasuhiro Katsu | N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| JP2005519917A (ja) * | 2002-02-01 | 2005-07-07 | オメロス コーポレイション | 軟骨分解の全身阻害のための組成物および方法 |
-
2003
- 2003-02-07 DE DE10304994A patent/DE10304994A1/de not_active Withdrawn
-
2004
- 2004-01-13 PE PE2004000064A patent/PE20040939A1/es not_active Application Discontinuation
- 2004-01-23 PT PT04704552T patent/PT1594520E/pt unknown
- 2004-01-23 ME MEP-410/08A patent/MEP41008A/xx unknown
- 2004-01-23 CN CNB2004800034498A patent/CN1317029C/zh not_active Expired - Fee Related
- 2004-01-23 PL PL376605A patent/PL206412B1/pl unknown
- 2004-01-23 KR KR1020057014116A patent/KR20050105447A/ko not_active Ceased
- 2004-01-23 EP EP04704552A patent/EP1594520B1/de not_active Expired - Lifetime
- 2004-01-23 RU RU2005127862/15A patent/RU2329057C2/ru not_active IP Right Cessation
- 2004-01-23 DE DE502004001159T patent/DE502004001159D1/de not_active Expired - Lifetime
- 2004-01-23 AT AT04704552T patent/ATE335500T1/de active
- 2004-01-23 BR BR0407333-9A patent/BRPI0407333A/pt not_active IP Right Cessation
- 2004-01-23 RS YUP-2005/0565A patent/RS51029B/sr unknown
- 2004-01-23 ES ES04704552T patent/ES2268622T3/es not_active Expired - Lifetime
- 2004-01-23 JP JP2006501585A patent/JP2006516980A/ja active Pending
- 2004-01-23 HR HRP20050701AA patent/HRP20050701B1/hr not_active IP Right Cessation
- 2004-01-23 MX MXPA05007310A patent/MXPA05007310A/es active IP Right Grant
- 2004-01-23 WO PCT/EP2004/000550 patent/WO2004069266A2/de not_active Ceased
- 2004-01-23 CA CA2514152A patent/CA2514152C/en not_active Expired - Fee Related
- 2004-01-23 NZ NZ541680A patent/NZ541680A/en not_active IP Right Cessation
- 2004-01-23 AU AU2004210396A patent/AU2004210396A1/en not_active Abandoned
- 2004-01-23 DK DK04704552T patent/DK1594520T3/da active
- 2004-02-05 TW TW093102562A patent/TW200505472A/zh unknown
- 2004-02-05 AR ARP040100363A patent/AR043036A1/es unknown
- 2004-02-06 MY MYPI20040362A patent/MY135827A/en unknown
-
2005
- 2005-06-27 ZA ZA200505177A patent/ZA200505177B/en unknown
- 2005-07-26 IL IL169899A patent/IL169899A0/en unknown
- 2005-08-03 CO CO05076615A patent/CO5690613A2/es not_active Application Discontinuation
- 2005-08-05 MA MA28425A patent/MA27618A1/fr unknown
- 2005-09-06 NO NO20054144A patent/NO333903B1/no not_active IP Right Cessation
-
2006
- 2006-10-16 CY CY20061101482T patent/CY1105708T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900211A1 (ru) | Замещенные производные имидазолона, их получение и применение | |
| EA200800555A1 (ru) | Производные ксантина в качестве селективных агонистов hm74a | |
| BR0112756A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto | |
| UY27976A1 (es) | Piperazinas heterocíclicas sustituídas para el tratamiento de la esquizofrenia | |
| BRPI0709581A8 (pt) | compostos de bicicloeteroarila como moduladores de px27 e seu uso | |
| UA111579C2 (uk) | ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ | |
| CY1109624T1 (el) | Υποκατεστημενα παραγωγα θειοφαινιου ως ανταγωνιστες υποδοχεα γλυκογονου, παρασκευη και θεραπευτικες χρησεις | |
| MA29088B1 (fr) | Composes d'indazole-carboxamide. | |
| DE602004012858D1 (de) | 2-aminobenzothiazole als cb1 rezeptor inverse agonisten | |
| NO20092470L (no) | Substituerte diazepanforbindelser som orexinreseptorantagonister | |
| BRPI0411840A2 (pt) | Método e aparelho para tratar osteoartrite, doença da cartilagem, defeitos e ferimentos no joelho humano. | |
| CY1110882T1 (el) | Ανταγωνιστες υποδοχεων ορεξινης υποκατεστημενης διαζεπανης | |
| BRPI0417376A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização | |
| UY26130A1 (es) | Compuestos para tratar la obesidad | |
| BRPI0713443A2 (pt) | Derivados de piperazinila úteis no tratamento de doenças medianas por receptor gpr38, uso e composição farmacêutica contendo tais compostos e processos para preparação dos mesmos | |
| BRPI0512274A (pt) | derivados de piperazina aril-substituìdos | |
| ATE418548T1 (de) | Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten | |
| BRPI0411661A (pt) | derivados de n-fenil-piperazina e métodos de profilaxia ou tratamento de doenças associadas com o receptor 5ht 2c | |
| ATE284398T1 (de) | N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten | |
| ATE495164T1 (de) | Thiadiazolderivate zur behandlung neurodegenerativer krankheiten | |
| BRPI0507120A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização | |
| ATE366572T1 (de) | 5-ht 1b/1d rezeptor agonisten zur behandlung von kopfschmerz der aus der verabreichung von endothelin rezeptor antagonisten resultiert | |
| ATE285794T1 (de) | Die verwendung von retinoid antagonisten oder agonisten für die behandlung von gelenk-und knochenpathologien | |
| BRPI0408117A (pt) | compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos | |
| BRPI0608437A2 (pt) | derivados tiazol fundidos que possuem afinidade para o receptor histamina h3 |